Regen BioPharma, Inc.
RGBP · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $2 | $0 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $177 | $150 | $122 | $95 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $179 | $152 | $179 | $160 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $18 | $18 | $18 | $18 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $18 | $18 | $18 | $18 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $197 | $169 | $197 | $178 |
| Liabilities | – | – | – | – |
| Payables | $30 | $34 | $36 | $30 |
| Short-Term Debt | $1,036 | $968 | $873 | $815 |
| Tax Payable | $29 | $4 | $0 | $0 |
| Deferred Revenue | $1,370 | $1,402 | $1,434 | $1,465 |
| Other Curr. Liab. | $1,801 | $1,712 | $2,199 | $1,805 |
| Total Curr. Liab. | $6,013 | $5,868 | $5,798 | $5,372 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $6,013 | $5,868 | $5,798 | $5,372 |
| Equity | – | – | – | – |
| Pref Stock | $1 | $1 | $1 | $1 |
| Common Stock | $3 | $2 | $2 | $1 |
| Retained Earnings | -$21,119 | -$20,952 | -$21,077 | -$20,616 |
| AOCI | -$205 | -$205 | $736 | $736 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$5,816 | -$5,698 | -$5,601 | -$5,194 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $197 | $169 | $197 | $178 |
| Net Debt | $1,034 | $966 | $873 | $814 |